Corpus Intelligence IC Memo — SOUTHEASTERN OHIO REG MED CTR 2026-04-26 16:27 UTC
IC Memo — SOUTHEASTERN OHIO REG MED CTR
Investment Committee Memorandum | OH | 86 beds | Grade C | EBITDA uplift $6.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SOUTHEASTERN OHIO REG MED CTR

CCN 360203 | GUERNSEY, OH | 86 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SOUTHEASTERN OHIO REG MED CTR is a 86-bed suburban community hospital in GUERNSEY, OH with $94.3M in net patient revenue and a -0.8% operating margin. The hospital serves a payer mix of 33.8% Medicare, 3.0% Medicaid, and 63.2% commercial.

Thesis: Turnaround. Our ML models identify $6.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.8% to 6.6% (+736bps).

Net Revenue HCRIS$94.3M
Current EBITDA COMPUTED$-725K
Operating Margin COMPUTED-0.8%
Occupancy HCRIS33.7%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS35.8%
Distress Probability ML52.6%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
97
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -0.8% places it below the state median. Among 97 size-comparable peers (43-172 beds), the median margin is 2.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (43-172), prioritizing same-state peers. 97 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SOUTHEASTERN OHIO REG MED CTR (Target)OH86$94.3M-0.8%
DUBLIN METHODIST HOSPITALOH110$333.9M28.4%
JEWISH HOSPITAL OF CINCINNATIOH170$333.6M-5.9%
WEST CHESTER HOSPITAL LLCOH163$318.7M-12.3%
BLANCHARD VALLEY REG. HEALTH COH152$310.1M22.8%
SOIN MEDICAL CENTEROH120$256.3M-1.3%
LIMA MEMORIAL HOSPITALOH110$253.5M6.4%
UH AHUJA MEDICAL CENTEROH153$249.4M3.3%
TRINITY HOSPITAL HOLDING COMPAOH162$244.3M-13.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.0M+210bp18mo
Cost to Collect4.5%2.5%$1.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.1M+122bp9mo
Clean Claim Rate88.0%96.0%$60K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.0M
Cost to Collect
$1.9M
Denial Rate Reduction
$1.9M
A/R Days Reduction
$1.1M
Clean Claim Rate
$60K
Total EBITDA Uplift$6.9M
Current EBITDA$-725K
+ RCM Uplift+$6.9M
Pro Forma EBITDA$6.2M
Current Margin-0.8%
Pro Forma Margin6.6%
WC Released (1x)$3.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.1M$64.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.1M$70.7M0.00x-100.0%
Bull Case9.0x11.0x$-1.0M$93.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.0M$101.5M0.00x-100.0%
Bear Case11.0x10.0x$-1.2M$30.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.2M$32.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 33.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 52.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 97 hospitals with 43-172 beds
  • Same-state prioritization (n=98)
  • Comp margins: P25=-13.1% / P50=2.7% / P75=9.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.